An investigation on behalf of investors of Bruker Corporation (NASDAQ:BRKR) shares over potential securities laws violations by Bruker and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Bruker Corporation (NASDAQ:BRKR) concerning whether a series of statements by Bruker Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Billerica, MA based Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Bruker Corporation reported that its annual Total Revenue declined from over $1.62 billion in 2015 to over $1.61 billion in 2016 and that its Net Income increased from $101.60 million in 2015 to $153.60 million in 2016.

Shares of Bruker Corporation (NASDAQ:BRKR) grew from $20.11 per share in October 2016 to $33.34 per share on November 3, 2017.

On November 9, 2017, Bruker Corporation advised investors that on October 19, 2017, Bruker Corporation received a notice of investigation and subpoena to produce documents from the U.S. Securities and Exchange Commission's ('SEC') Division of Enforcement. Bruker Corporation said that the SEC subpoena seeks information related to an employee terminated as part of a restructuring and matters involving Company policies, accounting practices related to revenue recognition and restructuring activities, as well as related financial reporting, disclosure and compliance matters since January 2013. Bruker Corporation furthermore stated that the subpoena also seeks information on previously identified material weakness in internal controls over accounting for income taxes, related financial reporting matters and certain payments for non-employee travel expenses.

Shares of Bruker Corporation (NASDAQ:BRKR) declined to $31.41 per share on November 10, 2017.